Tagged with IRA

BIO Chair Ted Love on IRA, US Election Outcomes & the Biosecure Act
Gilead CEO Named New PhRMA Board Chair; Inherits a Litany of Challenges
The IRA & Uncertain Times for US Pharma
Faced with IRA Challenges, BIO Names New CEO: Washington Fixture John Crowley
Peter DeYoung – CEO, Global Pharma, Piramal Pharma Limited
New NIH Director Bertagnolli to Focus on Access
Spain Pharma News Roundup: Almirall/EpimAb Biotherapeutics Deal; Insud Pharma India Site
HTA in the Middle East & Africa: Differentiated Approaches
First Ten Drugs Subject to Medicare Pricing Negotiations
Sara Al Dallal – President, Emirates Health Economics Society
Andrew Bird – Interim Chief Executive Officer, Acino
Merck’s IRA Lawsuit Comes Under Fire from Own Shareholders
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here